320 related articles for article (PubMed ID: 31830749)
1. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.
Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T
Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749
[TBL] [Abstract][Full Text] [Related]
2. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
[TBL] [Abstract][Full Text] [Related]
3. High Prevalence of Moyamoya Syndrome in Appalachia.
Nisiewicz MJ; Roberts JM; Dobbs MR; Ajadi EA; Kitzman P; Wolfe M; Elkins K; Dugan AJ; Fraser JF
Cerebrovasc Dis; 2020; 49(5):516-521. PubMed ID: 33027801
[TBL] [Abstract][Full Text] [Related]
4. Comparison between moyamoya disease and moyamoya syndrome in Israel.
Schwartzmann Y; Spektor S; Moscovici S; Jubran H; Metanis I; Jouaba T; Cohen JE; Gomori JM; Leker RR
J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107635. PubMed ID: 38342272
[TBL] [Abstract][Full Text] [Related]
5. Association of apolipoprotein E gene polymorphism with small-vessel lesions and stroke type in moyamoya disease: a preliminary study.
Jang DK; Huh PW; Lee KS
J Neurosurg; 2016 Jun; 124(6):1738-45. PubMed ID: 26566210
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Natural History of Quasi-Moyamoya Disease.
Zhao M; Lin Z; Deng X; Zhang Q; Zhang D; Zhang Y; Wang R; Wang S; Jiang Z; Wang H; Zhao J
J Stroke Cerebrovasc Dis; 2017 May; 26(5):1088-1097. PubMed ID: 28109734
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic cerebral microbleeds in adult patients with moyamoya disease: a prospective cohort study with 2 years of follow-up.
Sun W; Yuan C; Liu W; Li Y; Huang Z; Zhu W; Li M; Xu G; Liu X
Cerebrovasc Dis; 2013; 35(5):469-75. PubMed ID: 23736000
[TBL] [Abstract][Full Text] [Related]
9. Microbleed Status and 3-Month Outcome After Intravenous Thrombolysis in 717 Patients With Acute Ischemic Stroke.
Turc G; Sallem A; Moulin S; Tisserand M; Machet A; Edjlali M; Baron JC; Leclerc X; Leys D; Mas JL; Cordonnier C; Oppenheim C
Stroke; 2015 Sep; 46(9):2458-63. PubMed ID: 26230857
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Associated Risk Factors of Cerebral Microbleeds in Egyptian Patients with Acute Ischemic Stroke and Atrial Fibrillation.
Elkhatib THM; Elsaid AF; Al-Molla RM; Khamis MEM; Fahmi RM
J Stroke Cerebrovasc Dis; 2020 May; 29(5):104703. PubMed ID: 32111450
[TBL] [Abstract][Full Text] [Related]
11. Difference in Cerebral Circulation Time between Subtypes of Moyamoya Disease and Moyamoya Syndrome.
Kang K; Lu J; Zhang D; Li Y; Wang D; Liu P; Li B; Ju Y; Zhao X
Sci Rep; 2017 May; 7(1):2587. PubMed ID: 28566764
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and clinical features of moyamoya disease in the USA.
Kainth D; Chaudhry SA; Kainth H; Suri FK; Qureshi AI
Neuroepidemiology; 2013; 40(4):282-7. PubMed ID: 23445954
[TBL] [Abstract][Full Text] [Related]
13. Disparities in the symptomatic presentation of Moyamoya disease in the United States: A nationwide all-payer analysis.
Fuentes AM; Chiu RG; Mehta AI
J Clin Neurosci; 2021 May; 87():92-96. PubMed ID: 33863543
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Prognostic Implications of Cerebral Microbleeds in Chinese Patients With Ischemic Stroke.
Lau KK; Wong YK; Teo KC; Chang RSK; Tse MY; Hoi CP; Chan CY; Chan OL; Cheung RHK; Wong EKM; Kwan JSK; Hui ES; Mak HKF
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29217662
[TBL] [Abstract][Full Text] [Related]
15. Spatial relationship between cerebral microbleeds, moyamoya vessels, and hematoma in moyamoya disease.
Kazumata K; Shinbo D; Ito M; Shichinohe H; Kuroda S; Nakayama N; Houkin K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1421-8. PubMed ID: 24529354
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Stroke Risk Factors between Symptomatic and Asymptomatic Patients in a North American Moyamoya Disease Cohort.
Kumar M; Larson A; Jabal MS; Rinaldo L; Savastano L; Lanzino G; Meyer F; Lehman V; Klaas J
Cerebrovasc Dis Extra; 2022; 12(2):72-75. PubMed ID: 35588715
[TBL] [Abstract][Full Text] [Related]
17. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
[TBL] [Abstract][Full Text] [Related]
18. Predictors of cerebral microbleeds in acute ischemic stroke and TIA patients.
Ovbiagele B; Saver JL; Sanossian N; Salamon N; Villablanca P; Alger JR; Razinia T; Kim D; Liebeskind DS
Cerebrovasc Dis; 2006; 22(5-6):378-83. PubMed ID: 16888379
[TBL] [Abstract][Full Text] [Related]
19. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
[TBL] [Abstract][Full Text] [Related]
20. Predictors of New Cerebral Microbleeds in Patients with Antiplatelet Drug Therapy.
Wobith M; Mayer C; Belke M; Haag A; Gerstner A; Teepker M; Strzelczyk A; Werner R; Hamer HM; Rosenow F; Menzler K; Knake S
J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1671-1677. PubMed ID: 27067881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
